These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37549603)

  • 41. DNA replication checkpoint control of Wee1 stability by vertebrate Hsl7.
    Yamada A; Duffy B; Perry JA; Kornbluth S
    J Cell Biol; 2004 Dec; 167(5):841-9. PubMed ID: 15583029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Ready, set, go": checkpoint regulation by Cdk1 inhibitory phosphorylation.
    Ayeni JO; Campbell SD
    Fly (Austin); 2014; 8(3):140-7. PubMed ID: 25483135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells.
    Lal S; Burkhart RA; Beeharry N; Bhattacharjee V; Londin ER; Cozzitorto JA; Romeo C; Jimbo M; Norris ZA; Yeo CJ; Sawicki JA; Winter JM; Rigoutsos I; Yen TJ; Brody JR
    Cancer Res; 2014 Feb; 74(4):1128-40. PubMed ID: 24536047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A role for Hsp90 in cell cycle control: Wee1 tyrosine kinase activity requires interaction with Hsp90.
    Aligue R; Akhavan-Niak H; Russell P
    EMBO J; 1994 Dec; 13(24):6099-106. PubMed ID: 7813446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome.
    Murrow LM; Garimella SV; Jones TL; Caplen NJ; Lipkowitz S
    Breast Cancer Res Treat; 2010 Jul; 122(2):347-57. PubMed ID: 19821025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1.
    Busch CJ; Kröger MS; Jensen J; Kriegs M; Gatzemeier F; Petersen C; Münscher A; Rothkamm K; Rieckmann T
    Radiother Oncol; 2017 Feb; 122(2):260-266. PubMed ID: 27939202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping of the interaction sites between Wee1 kinase and the regulatory beta-subunit of protein kinase CK2.
    Olsen BB; Kreutzer JN; Watanabe N; Holm T; Guerra B
    Int J Oncol; 2010 May; 36(5):1175-82. PubMed ID: 20372791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
    Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
    Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.
    Knight GL; Turnell AS; Roberts S
    J Virol; 2006 Aug; 80(15):7416-26. PubMed ID: 16840322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell cycle regulation of human WEE1.
    McGowan CH; Russell P
    EMBO J; 1995 May; 14(10):2166-75. PubMed ID: 7774574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy.
    Yang L; Shen C; Pettit CJ; Li T; Hu AJ; Miller ED; Zhang J; Lin SH; Williams TM
    Clin Cancer Res; 2020 Jul; 26(14):3740-3750. PubMed ID: 32220892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1.
    Chang KL; Kung ML; Chow NH; Su SJ
    Biochem Pharmacol; 2004 Feb; 67(4):717-26. PubMed ID: 14757171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation.
    O'Connell MJ; Raleigh JM; Verkade HM; Nurse P
    EMBO J; 1997 Feb; 16(3):545-54. PubMed ID: 9034337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer.
    Murakami K; Kita Y; Sakatani T; Hamada A; Mizuno K; Nakamura K; Takada H; Matsumoto K; Sano T; Goto T; Akamatsu S; Saito R; Tsuruyama T; Ogawa O; Kobayashi T
    Cancer Sci; 2021 Sep; 112(9):3669-3681. PubMed ID: 34212455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer.
    Sen T; Tong P; Diao L; Li L; Fan Y; Hoff J; Heymach JV; Wang J; Byers LA
    Clin Cancer Res; 2017 Oct; 23(20):6239-6253. PubMed ID: 28698200
    [No Abstract]   [Full Text] [Related]  

  • 56. Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors.
    Liu W; Zeng X; Yin Y; Li C; Yang W; Wan W; Shi L; Wang G; Tao K; Zhang P
    Gastric Cancer; 2020 Jan; 23(1):39-51. PubMed ID: 31197522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ability of CK2beta to selectively regulate cellular protein kinases.
    Olsen BB; Guerra B
    Mol Cell Biochem; 2008 Sep; 316(1-2):115-26. PubMed ID: 18560763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. WEE1 inhibition enhances sensitivity to hypoxia/reoxygenation in HeLa cells.
    Goto T; Homma H; Kaida A; Miura M
    J Radiat Res; 2019 Oct; 60(5):709-713. PubMed ID: 31347653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo.
    Nguyen TH; Ong CK; Wong E; Leong CT; Panasci L; Huynh H
    Int J Oncol; 2005 Oct; 27(4):1131-40. PubMed ID: 16142332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genistein induces G2/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression.
    Liu YL; Zhang GQ; Yang Y; Zhang CY; Fu RX; Yang YM
    Nutr Cancer; 2013; 65(7):1034-41. PubMed ID: 24053672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.